Kalle Mattila - UTU Research Portal

Kalle Mattila

Clinical Oncology (Department of Clinical Medicine)

kalmat@utu.fi

1 of 2

Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free survival in clear cell renal cell carcinoma (2024)
- Cancer Medicine
Luomala Lassi, Mattila Kalle, Vainio Paula, Nisén Harry, Pellinen Teijo, Lohi Jouni, Laajala Teemu D., Järvinen Petrus, Koskenniemi Anna-Riina, Jaakkola Panu, Mirtti Tuomas
Real-world results of first-line immunotherapy or targeted therapy for metastatic melanoma in Finland: a cohort study (2024)
- Future Oncology
Mattila, Kalle E; Tiainen, Leena; Vikkula, Johanna; Kreutzman, Anna; Engström-Risku, Mia; Kysenius, Kai; Hölsä, Olivia; Hernesniemi, Sari; Hemmilä, Päivikki; Pystynen, Anssi; Mäkelä, Siru
Reasons for Treatment Discontinuation and Their Effect on Outcomes of Immunotherapy in Southwest Finland: A Retrospective, Real-World Cohort Study (2024)
- Cancers
Virtanen Saana, Pihlman Heidi, Silvoniemi Maria, Vihinen Pia, Jaakkola Panu, Mattila Kalle E.
The impact of prognostic factors and comorbidities on survival in older adults with stage I − III cutaneous melanoma in Southwest Finland: A register study (2024)
- Journal of Geriatric Oncology
Mattila Kalle E., Vihinen Helmi, Heervä Eetu, Nuotio Maria S., Vihinen Pia
Antibiotic Treatment is an Independent Poor Risk Factor in NSCLC But Not in Melanoma Patients Who had Received Anti-PD-1/L1 Monotherapy (2023)
- Clinical Lung Cancer
Vihinen Hannes, Jokinen Artturi, Laajala Teemu D, Wahid Nesna, Peltola Lotta, Kettunen Tiia, Rönkä Aino, Tiainen Leena, Skyttä Tanja, Kohtamäki Laura, Tulokas Sanni, Karhapää Hanna, Hernberg Micaela, Silvoniemi Maria, Mattila Kalle E
Ei-melanoottisten ihosyöpien nykyhoito (2023)
- Duodecim
Mattila Kalle, Riihilä Pilvi, Veräjänkorva Esko, Mäkelä Siru
Observational study on the evolution of systemic treatments for advanced renal cell carcinoma in Southwest Finland between 2010 and 2021 (2023)
- Therapeutic Advances in Urology
Hölsä Olivia, Teittinen Kaisa, Anttalainen Anna, Ukkola-Vuoti Liisa, Summanen Milla, Mattila Kalle E.
Paikallisesti edenneen ihomelanooman hoito ja ihomelanooman esiliitännäishoito (2023)
- Duodecim
Mattila Kalle, Veräjänkorva Esko, Koskivuo Ilkka, Heervä Eetu, Vihinen Pia, Hernberg Micaela
Radium-223 dichloride treatment in metastatic castration-resistant prostate cancer in Finland: A real-world evidence multicenter study (2023)
- Cancer Medicine
Hyväkkä Anniina, Kääriäinen Okko-Sakari, Utriainen Tapio, Löyttyniemi Eliisa, Mattila Kalle, Reinikainen Petri, Sormunen Jorma, Jääskeläinen Minna, Auvinen Päivi, Minn Heikki, Sundvall Maria
Smoking is an Independent Marker of Poor Prognosis in Cutaneous Melanoma (2023)
- Acta Dermato-Venereologica
Mattila Kalle, Vihinen Helmi, Karlsson Antti, Minn Heikki, Vihinen Pia, Heervä Eetu
Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor (2022)
- Acta Oncologica
Mattila Kalle E., Mäkelä Siru, Kytölä Soili, Andersson Emma, Vihinen Pia, Ramadan Susan, Skyttä Tanja, Tiainen Leena, Vuoristo Meri-Sisko, Tyynelä-Korhonen Kristiina, Koivunen Jussi, Kohtamäki Laura, Aittomäki Kristiina, Hernberg Micaela
Edenneen munuaissyövän hoito (2022)
- Duodecim
Mattila Kalle, Peltola Katriina, Jaakkola Panu
Immuuniaktivaation vapauttajien, kaksoisspesifisten vasta-aineiden ja CAR-T-soluhoitojen sydänhaitat (2022)
- Duodecim
Laurila Sanna, Mattila Kalle, Arponen Otso, Skyttä Tanja
Novel prognostic factors for advanced melanoma and localized renal cell carcinoma (2022) Mattila Kalle E.
Prognostic Factors for Localized Clear Cell Renal Cell Carcinoma and Their Application in Adjuvant Therapy (2022)
- Cancers
Mattila Kalle E., Vainio Paula, Jaakkola Panu M.
Retrospective, Registry-based, Cohort Investigation of Clinical Outcomes in Patients with Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma in Finland (2022)
- Acta Dermato-Venereologica
Tuominen Samuli, Ukkola-Vuoti Liisa, Riihilä Pilvi, Knuutila Jaakko S, Kähäri Veli-Matti, Lassenius Mariann, Ranki Tuuli, Pousar Katariina, Vassilev Lotta, Vuoti Sauli, Mattila Kalle
Survival of Women Previously Diagnosed of Melanoma with Subsequent Pregnancy: A Systematic Review and Meta-Analysis and a Single-Center Experience (2022)
- Journal of Clinical Medicine
Martinez-Campayo Nieves, de la Morena Sabela P, Pértega-Diaz Sonia, Pena Luisa Iglesias, Vihinen Pia, Mattila Kalle, Lens Marko B, Tejera-Vaquerizo Antonio, Fonseca Eduardo
Tutkijalähtöinen kliininen lääketutkimus syöpäpotilailla - miten pystytän ja hoidan (2022)
- Duodecim
Mattila Kalle, Penttilä Kirsi, Vihinen Pia
Uptake of 18F-rhPSMA-7.3 in Positron Emission Tomography Imaging of Prostate Cancer: A Phase 1 Proof-of-Concept Study (2022)
- Cancer Biotherapy and Radiopharmaceuticals
Malaspina Simona, Taimen Pekka, Kallajoki Markku, Oikonen Vesa, Kuisma Anna, Ettala Otto, Mattila Kalle, Boström Peter J, Minn Heikki, Kalliokoski Kari, Postema Ernst J, Miller Matthew P, Scheinin Mika
A three-feature prediction model for metastasis-free survival after surgery of localized clear cell renal cell carcinoma (2021)
- Scientific Reports
Mattila Kalle E., Laajala Teemu D., Tornberg Sara V., Kilpeläinen Tuomas P., Vainio Paula, Ettala Otto, Boström Peter J., Nisen Harry, Elo Laura L., Jaakkola Panu M.